147 related articles for article (PubMed ID: 19051901)
1. Effect of poly(D, L-lactic acid) nanoparticles as triptolide carrier on abating rats renal toxicity by NMR-based metabolic analysis.
Liu M; Dong J; Yang Y; Yang X; Xu H
J Nanosci Nanotechnol; 2008 Jul; 8(7):3493-9. PubMed ID: 19051901
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
[TBL] [Abstract][Full Text] [Related]
3. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
4. Acute and subacute toxicity studies on triptolide and triptolide-loaded polymeric micelles following intravenous administration in rodents.
Xu L; Qiu Y; Xu H; Ao W; Lam W; Yang X
Food Chem Toxicol; 2013 Jul; 57():371-9. PubMed ID: 23583804
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
[TBL] [Abstract][Full Text] [Related]
6. Gender Differences in the Toxicokinetics of Triptolide after Single- and Multiple-dose Administration in Rats.
Liu L; Zhang J; Wang Z; Xu D; Jiang Z; Wang T; Ju W; Zhang L
Drug Res (Stuttg); 2015 Nov; 65(11):602-6. PubMed ID: 25647231
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory effects of triptolide loaded poly(D,L-lactic acid) nanoparticles on adjuvant-induced arthritis in rats.
Liu M; Dong J; Yang Y; Yang X; Xu H
J Ethnopharmacol; 2005 Feb; 97(2):219-25. PubMed ID: 15707756
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide.
Zheng Q; Gong T; Sun X; Zhang ZR
Arch Pharm Res; 2006 Dec; 29(12):1164-70. PubMed ID: 17225468
[TBL] [Abstract][Full Text] [Related]
9. Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide.
Shan QQ; Jiang XJ; Wang FY; Shu ZX; Gui SY
Drug Deliv; 2019 Dec; 26(1):490-498. PubMed ID: 31081409
[TBL] [Abstract][Full Text] [Related]
10. Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin.
Yuan ZX; Wu XJ; Mo J; Wang YL; Xu CQ; Lim LY
Eur J Pharm Biopharm; 2015 Aug; 94():363-71. PubMed ID: 26117184
[TBL] [Abstract][Full Text] [Related]
11. Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity.
Zheng W; Wang C; Ding R; Huang Y; Li Y; Lu Y
Int J Pharm; 2019 Dec; 572():118721. PubMed ID: 31626922
[TBL] [Abstract][Full Text] [Related]
12. Involvement of oxidative stress in the mechanism of triptolide-induced acute nephrotoxicity in rats.
Yang F; Ren L; Zhuo L; Ananda S; Liu L
Exp Toxicol Pathol; 2012 Nov; 64(7-8):905-11. PubMed ID: 21530203
[TBL] [Abstract][Full Text] [Related]
13. A renal-targeted triptolide aminoglycoside (TPAG) conjugate for lowering systemic toxicities of triptolide.
Qi B; Wang X; Zhou Y; Han Q; He L; Gong T; Sun X; Fu Y; Zhang Z
Fitoterapia; 2015 Jun; 103():242-51. PubMed ID: 25869848
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis.
Zhang L; Chang J; Zhao Y; Xu H; Wang T; Li Q; Xing L; Huang J; Wang Y; Liang Q
Int J Nanomedicine; 2018; 13():2051-2064. PubMed ID: 29670349
[TBL] [Abstract][Full Text] [Related]
15. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle.
Mei Z; Li X; Wu Q; Hu S; Yang X
Pharmacol Res; 2005 Apr; 51(4):345-51. PubMed ID: 15683748
[TBL] [Abstract][Full Text] [Related]
16. Triptolide delivery: Nanotechnology-based carrier systems to enhance efficacy and limit toxicity.
Ren Q; Li M; Deng Y; Lu A; Lu J
Pharmacol Res; 2021 Mar; 165():105377. PubMed ID: 33484817
[TBL] [Abstract][Full Text] [Related]
17. Role of reactive oxygen species in triptolide-induced apoptosis of renal tubular cells and renal injury in rats.
Yang F; Zhuo L; Ananda S; Sun T; Li S; Liu L
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):335-341. PubMed ID: 21671174
[TBL] [Abstract][Full Text] [Related]
18. Excretion of [3H]triptolide and its metabolites in rats after oral administration.
Liu J; Zhou X; Chen XY; Zhong DF
Acta Pharmacol Sin; 2014 Apr; 35(4):549-54. PubMed ID: 24632843
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo.
Zhang L; Wang T; Li Q; Huang J; Xu H; Li J; Wang Y; Liang Q
Int J Nanomedicine; 2016; 11():2663-73. PubMed ID: 27354796
[TBL] [Abstract][Full Text] [Related]
20. Effect of triptolide on expression of oxidative carbonyl protein in renal cortex of rats with diabetic nephropathy.
Dong XG; An ZM; Guo Y; Zhou JL; Qin T
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):25-29. PubMed ID: 28224432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
